Welcome : Guest

INTRACRANIAL STENTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as -

Admedes Schuessler GmbH
BALT Extrusion
Cardiatis SA
Codman & Shurtleff, Inc.
Covidien PLC

Click here to request a full list of companies covered in the report...

Code: MCP-7795
Price: $4950
Companies: 14
Pages: 94
Date: January 2015
Market Data Tables: 24
 



TABLE OF CONTENTS


  INTRACRANIAL STENTS (Complete Report) Pages : 94   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Growing Importance of Intracranial Stents in Neurovascular Disease.....II-1
Table 1: Global Neurovascular Intervention Market by Technique (2014): Percentage Share Breakdown for Embolization, Revascularization, Support Devices, and Mechanical Thrombectomy (includes corresponding Graph/Chart).....II-1
1$350
   The Global Intracranial Stents Market - Adversely Impacted by the SAMMPRIS
  Study.....II-2
1$100
   SAMMPRIS Study: An Insight.....II-31$100
   Rising Geriatric Population – A Major Growth Driver for the ICS Market.....II-4 1$100
   Table 2: Elderly Population (65+ Years) as a Percentage of the Total Population: 2000 & 2025 (includes corresponding Graph/Chart).....II-51$350
   Table 3: Global Population Statistics for the 65+ Age Group: 2012 (includes corresponding Graph/Chart).....II-61$350
   Table 4: Life Expectancy at Age 60 and 80 Years- (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart).....II-7
Market Challenges.....II-7
Technological Challenges.....II-7
Safety and Efficacy.....II-7
1$350
   Regulatory Challenges.....II-8
Price Factor.....II-8
1$100
   APOLLO Stent System.....II-9
WILLIS® Intracranial Stent Graft System.....II-9
Neuroform EZ® Stent System.....II-9
Wingspan® Stent System.....II-9
1$100
   Self-Expandable LEO.....II-10
Micrus® Pharos™ Vitesse™ Intracranial Stent.....II-10
Solitaire AB Neurovascular Remodeling Device.....II-10
1$100
   Changing Lifestyle Conditions Stoking Risk of Cerebrovascular Diseases.....II-11
Rising Stroke Statistics – An Opportunity Indicator.....II-11
1$100
   Rising Number of Restenosis Cases Boosts Demand for Stenting.....II-12
Asians at Highest Risk of Intracranial Atherosclerosis Disease.....II-12
Cardiovascular Stent Manufacturers Diversify Into the Neurovascular Market.....II-12
1$100
   QMRA Facilitates Detection of In-stent Stenosis.....II-13
MNCs Weave Strategies to Tap Growth Centers in Emerging Markets.....II-13
1$100
   Medical Tourism Buoys Demand for Stenting Procedures in Emerging Nations.....II-14
Rising Road Accidents Lead to Increasing Number of Stenting Procedures.....II-14
1$100
   Table 5: Global Rate of Road Fatalities by Economic Status of Countries (2014): Percentage Rate of Road Fatalities per 100,000 Residents for Low, Mid and High Per Capita Income Regions (includes corresponding Graph/Chart).....II-151$350
   Intracranial Stenting.....II-16
Stents.....II-16
Evolution.....II-16
1$100
   Types of Stents.....II-17
Bare Metal Stents (BMS).....II-17
Drug Eluting Stents.....II-17
1$100
   Self-Expanding Stents.....II-18
Post-Treatment Management.....II-18
Anti-Platelet Therapy.....II-18
1$100
   Surveillance Imaging.....II-191$100
   Introduction.....II-20
Diagnosis of Intracranial Stenosis.....II-20
Differential Diagnosis.....II-20
1$100
   Neuroimaging Screening.....II-21
Anatomic Diagnosis.....II-21
Digital Subtraction Angiography.....II-21
Transcranial Doppler.....II-21
Magnetic Resonance Angiography (MRA).....II-21
1$100
   Positron Emission Tomography (PET).....II-22
Computerized Tomography (CT) Perfusion.....II-22
Treatment Procedures for Intracranial Stenosis.....II-22
Medication.....II-22
Anticoagulants or Blood Thinners.....II-22
Cholesterol Lowering Drugs.....II-22
1$100
   Blood Pressure Medications.....II-23
Surgical Procedures.....II-23
Stenting/Balloon Angioplasty.....II-23
Cerebral Artery Bypass.....II-23
1$100
   Ischemic Stroke.....II-24
Symptoms, Indications, and Complications Associated with Stroke.....II-24
Posterior Circulation Stroke.....II-24
Anterior Circulation Stroke.....II-24
Non-Specific Signs.....II-24
Some Major Risk Factors for Stroke.....II-24
1$100
   Intracranial Atherosclerotic Disease (ICAD).....II-25
Risk Factors.....II-25
Treatment Options for ICAD.....II-25
1$100
   Brain Aneurysms/Cerebral Aneurysm/ Intracranial Aneurysm.....II-26
Aneurysm – Quick Facts.....II-26
Symptoms of Unruptured Aneurysm.....II-26
Risk Factors for Aneurysm.....II-26
1$100
   Detection Methods.....II-27
Table 6: Comparison of Sensitivity and Specificity of Computed Tomography Angiography (CTA), Transcranial Doppler Sonography (TCD) and Magnetic Resonance Angiography (MRA) in the Diagnosis of Intracranial Aneurysms (includes corresponding Graph/Chart).....II-27
1$350
   Table 7: Percentage Mortality, Morbidity, and Re-bleeding Rate of Intervention Associated with Intracranial Aneurysms.....II-28
Arterial Dissection.....II-28
Diagnosis.....II-28
Treatment.....II-28
Restenosis.....II-28
1$350
   CFDA Approves New Specifications of MicroPort’s Apollo Stent System (China).....II-29
MicroPort’s WILLIS® Intracranial Stent Graft System Receives China SFDA
  Approval.....II-29
Phenox’s pCONus Bifurcation Aneurysm Implant Obtains CE-Mark Approval.....II-29
Acandis’ Acclino 1.9-F Stent System Receives CE Mark Approval.....II-29
ITGI Medical Obtains CE Mark Approval for AneuGraft Nx.....II-29
1$100
   MicroVention Enrolls in Clinical Trial for Its FRED™ System (US).....II-30
Admedes Schuessler to Expand Nitinol Manufacturing Capacity.....II-30
STAR Study Results Establish Safety and Efficacy of Solitaire™ FR Device in Acute
  Ischemic Stroke Treatment.....II-30
MicroPort Scientific Announces Inauguration of MicroPort NeuroTech.....II-30
Purdue University Scientists Study Stents Coated with Nanotechnology-Enhanced Drug for
  Treatment of Aneurysms.....II-30
1$100
   Admedes Schuessler GmbH (Germany).....II-31
BALT Extrusion (France).....II-31
Cardiatis SA (Belgium).....II-31
1$100
   Codman & Shurtleff, Inc. (US).....II-32
Covidien PLC (Ireland).....II-32
1$100
   ITGI Medical Ltd. (Israel).....II-33
MicroPort Scientific Corporation (China).....II-33
1$100
   OBEX Medical (New Zealand).....II-34
Stryker Corp. (US).....II-34
1$100
   Table 8: World Recent Past, Current & Future Analysis for Intracranial Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart).....II-351$350
   Table 9: World Historic Review for Intracranial Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart).....II-361$350
   Table 10: World 14-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for the Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-371$350
   A. Market Analysis.....III-1
The Largest Market for Intracranial Stents Globally.....III-1
SAMMPRIS Study Results – A Major Blow to the US ICS Market.....III-1
2$190
   Ageing Demographics: A Key Market Driver.....III-3
Table 11: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-3
1$200
   Regulatory Status of Intracranial Stents in the United States.....III-4
Intracranial Stenting among Medicare Beneficiaries during the Years
  2006-2010.....III-4
Strategic Corporate Developments.....III-4
1$95
   Select Key Players.....III-52$190
   B. Market Analytics.....III-7
Table 12: The US Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart).....III-7
1$200
   Table 13: The US Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart).....III-81$200
   A. Market Analysis.....III-9
Negative Effects of SAMMPRIS Study Expand to European Market.....III-9
Increasing Geriatric Population Segment: A Business Case for ICS.....III-9
1$200
   Table 14: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart).....III-101$200
   Focus on Select Regional Markets.....III-11
France.....III-11
French Government Imposes Regulations on Advertisement of High-risk Medical
  Devices.....III-11
The United Kingdom.....III-11
Stroke Statistics in the UK.....III-11
Table 15: Breakdown of Total Number of Deaths Due to Strokes by Age and Sex in the UK: 2010 (includes corresponding Graph/Chart).....III-11
1$200
   Product Approvals.....III-12
Strategic Corporate Development.....III-12
Select Key Players.....III-12
2$190
   B. Market Analytics.....III-14
Table 16: European Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart).....III-14
1$200
   Table 17: European Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart).....III-151$200
   A. Market Analysis.....III-16
Developing Regions Poised to Witness Faster Growth.....III-16
Price Sensitivity of Asian Consumers – A Crucial Factor.....III-16
India & China Offer Significant Growth Opportunities.....III-16
1$190
   Table 18: China and India Leads Global Population (July 2013): Table Depicting China and India’s Huge Population Vis-a-vis Other Countries’ Population (in Million) by Age Group (includes corresponding Graph/Chart).....III-171$200
   Table 19: Age-wise Breakup of China and India’s Population Vis-à-vis Other Populous Countries Globally: As of July 2013 (includes corresponding Graph/Chart).....III-18
Select Regional Markets.....III-18
Australia.....III-18
Stroke Statistics in Australia.....III-18
1$200
   Table 20: Stroke Prevalence in Australia Age and Gender: 2012 (includes corresponding Graph/Chart).....III-19
Leading Risk Factors for Stroke-Related Fatalities: Ranking Based on Number
  of Deaths (2012).....III-19
China.....III-19
Healthcare Reforms and New Product Approval to Propel Market Growth.....III-19
1$200
   Table 21: Chinese Neurovascular Stents Market by Leading Brand (2013): Percentage Market Share Breakdown of Units Sold for Apollo, Wingspan, and Others (includes corresponding Graph/Chart).....III-20
APOLLO – Tried and tested Stent System.....III-20
WILLIS® to Target Bright Market Prospects in China.....III-20
1$200
   India.....III-21
Changes in Lifestyle Demographic and Socioeconomic Factors Increase Stroke
  Prevalence.....III-21
Stroke Statistics.....III-21
Management and Treatment of Stroke Presents a Daunting Task.....III-21
Kerala – Gaining Prominence for Neurovascular Therapy.....III-21
1$95
   Japan.....III-22
Japanese Intracranial Stents Market.....III-22
Table 22: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-22
1$200
   Studies Validate Effectiveness of Endovascular Therapy for Treatment of
  Intracranial Aneurysm.....III-23
Product Approvals.....III-23
1$95
   Strategic Corporate Development.....III-24
Select Key Players.....III-24
2$190
   B. Market Analytics.....III-26
Table 23: Rest of World Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart).....III-26
1$200
   Table 24: Rest of World Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart).....III-271$200
  
Total Companies Profiled: 14 (including Divisions/Subsidiaries - 17)

Region/Country Players

The United States 6 Europe 6 France 1 Germany 3 Rest of Europe 2 Asia-Pacific (Excluding Japan) 4 Middle East 1
Click here to request a full table of contents and more details on this project.